Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Condition(s):Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)Last Updated:September 11, 2023Completed